Sari L Reisner1,2,3,4, Chiara S Moore1, Andrew Asquith1, Dana J Pardee1, Kenneth H Mayer1,3,5,6. 1. The Fenway Institute, Fenway Health, Boston, Massachusetts, USA. 2. Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, Massachusetts, USA. 3. Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. 4. Department of Epidemiology and Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. 5. Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. 6. Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Abstract
Purpose: This analysis was designed to characterize the pre-exposure prophylaxis (PrEP) cascade in a U.S. national sample of transgender men and trans masculine adults who have sex with cisgender men (trans MSM) at-risk for HIV acquisition. Methods: From November to December 2017, 843 HIV-negative trans MSM self-reporting past-6-month receptive sex with a cisgender man were recruited via peer referrals, dating apps, listservs, and social media. A computer-assisted self-interview assessed demographics, health care, and the PrEP cascade. Descriptive statistics and multivariable regression models evaluated factors associated with PrEP uptake and persistence. Results: Mean age was 28.1 years (standard deviation = 7.1); 4.8% were Black, 21.7% Latinx, and 25.6% another race/ethnicity. A total of 84.1% had heard of PrEP, with 67.3% reporting interest. More than half (55.2%) were PrEP indicated, of which 50.8% were PrEP naive. Approximately 1/4 (28.0%) reported PrEP use, of which 65.3% were PrEP persistent. PrEP modality preferences were injectable (51.2%), daily oral pill (22.1%), and anal gel/lube (14.6%). Reasons for PrEP noninterest were no HIV risk (68.5%), cost (24.2%), and side effects (20.1%). Surgical gender affirmation, no health care discrimination, and social media as a primary health information source were associated with increased odds of PrEP uptake and persistence (all p < 0.05). PrEP adherence difficulties were reported by 52.6%, due to busy/inconsistent schedule (53.1%), side effects (27.4%), and too many medical visits (11.6%). Conclusion: PrEP uptake was modest among the trans MSM sampled, given prevalent HIV risk behaviors. The limited PrEP uptake in at-risk trans MSM suggests the need to develop culturally tailored community education and interventions.
Purpose: This analysis was designed to characterize the pre-exposure prophylaxis (PrEP) cascade in a U.S. national sample of transgender men and trans masculine adults who have sex with cisgender men (trans MSM) at-risk for HIV acquisition. Methods: From November to December 2017, 843 HIV-negative trans MSM self-reporting past-6-month receptive sex with a cisgender man were recruited via peer referrals, dating apps, listservs, and social media. A computer-assisted self-interview assessed demographics, health care, and the PrEP cascade. Descriptive statistics and multivariable regression models evaluated factors associated with PrEP uptake and persistence. Results: Mean age was 28.1 years (standard deviation = 7.1); 4.8% were Black, 21.7% Latinx, and 25.6% another race/ethnicity. A total of 84.1% had heard of PrEP, with 67.3% reporting interest. More than half (55.2%) were PrEP indicated, of which 50.8% were PrEP naive. Approximately 1/4 (28.0%) reported PrEP use, of which 65.3% were PrEP persistent. PrEP modality preferences were injectable (51.2%), daily oral pill (22.1%), and anal gel/lube (14.6%). Reasons for PrEP noninterest were no HIV risk (68.5%), cost (24.2%), and side effects (20.1%). Surgical gender affirmation, no health care discrimination, and social media as a primary health information source were associated with increased odds of PrEP uptake and persistence (all p < 0.05). PrEP adherence difficulties were reported by 52.6%, due to busy/inconsistent schedule (53.1%), side effects (27.4%), and too many medical visits (11.6%). Conclusion: PrEP uptake was modest among the trans MSM sampled, given prevalent HIV risk behaviors. The limited PrEP uptake in at-risk trans MSM suggests the need to develop culturally tailored community education and interventions.
Authors: Ian M McGowan; Ratiya Pamela Kunjara Na Ayudhya; Rhonda M Brand; Mark A Marzinke; Craig W Hendrix; Sherri Johnson; Jeanna Piper; Timothy H Holtz; Marcel E Curlin; Anupong Chitwarakorn; Boonyos Raengsakulrach; Gustavo Doncel; Jill L Schwartz; James F Rooney; Ross D Cranston Journal: AIDS Res Hum Retroviruses Date: 2021-10-29 Impact factor: 1.723
Authors: Pedro B Carneiro; Victoria Frye; Chloe Mirzayi; Viraj Patel; David Lounsbury; Terry T-K Huang; Nasim Sabounchi; Christian Grov Journal: AIDS Educ Prev Date: 2022-06
Authors: Diana M Tordoff; Sahar Zangeneh; Christine M Khosropour; Sara N Glick; Raymond Scott McClelland; Dobromir Dimitrov; Sari Reisner; Ann Duerr Journal: J Acquir Immune Defic Syndr Date: 2022-04-15 Impact factor: 3.771
Authors: Maria Pyra; Russell Brewer; Laura Rusie; Jeanelle Kline; India Willis; John Schneider Journal: J Acquir Immune Defic Syndr Date: 2022-02-01 Impact factor: 3.771
Authors: Karine Dubé; John Kanazawa; Chadwick Campbell; Cheriko A Boone; Allysha C Maragh-Bass; Danielle M Campbell; Moisés Agosto-Rosario; Jamila K Stockman; Dázon Dixon Diallo; Tonia Poteat; Mallory Johnson; Parya Saberi; John A Sauceda Journal: AIDS Res Hum Retroviruses Date: 2021-05-31 Impact factor: 2.205
Authors: J Carlo Hojilla; Leo B Hurley; Julia L Marcus; Derek D Satre; Michael J Silverberg; Eve F Zaritsky; Darios Getahun; Michael Goodman; Jonathan E Volk Journal: J Acquir Immune Defic Syndr Date: 2022-03-01 Impact factor: 3.771